mercaptoethanol has been researched along with Brain Disorders in 10 studies
Mercaptoethanol: A water-soluble thiol derived from hydrogen sulfide and ethanol. It is used as a reducing agent for disulfide bonds and to protect sulfhydryl groups from oxidation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ifosfamide and mesna were administered to 77 patients with advanced malignancies." | 1.27 | Prediction of ifosfamide/mesna associated encephalopathy. ( Blackledge, G; Blake, AE; Honigsberger, L; Kelly, KA; Meanwell, CA, 1986) |
| "A case of reversible encephalopathy after one dose of ifosfamide/mesna in an epileptic 15-year-old girl is reported." | 1.27 | Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity. ( Carde, P; Droz, JP; Flamant, F; Friedman, S; Ghosn, M; Hayat, M; Leclerq, B, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verdeguer, A | 1 |
| Castel, V | 1 |
| Esquembre, C | 1 |
| Ferris, J | 1 |
| Fernandez, JM | 1 |
| Ruiz, JG | 1 |
| Meanwell, CA | 3 |
| Blake, AE | 2 |
| Latief, TN | 1 |
| Blackledge, G | 3 |
| Mould, JJ | 1 |
| Blake, DR | 1 |
| Shaw, IC | 1 |
| Honigsberger, L | 2 |
| Spooner, D | 1 |
| Williams, AC | 1 |
| Cantwell, BM | 1 |
| Harris, AL | 1 |
| Kelly, KA | 2 |
| Perren, TJ | 1 |
| Turner, RC | 1 |
| Smith, IE | 1 |
| Beuzeboc, P | 1 |
| Dorval, T | 1 |
| Garcia-Giralt, E | 1 |
| Jouve, M | 1 |
| Livartowski, A | 1 |
| Palangie, T | 1 |
| Scholl, S | 1 |
| Pouillart, P | 1 |
| Salloum, E | 1 |
| Flamant, F | 2 |
| Ghosn, M | 2 |
| Taleb, N | 1 |
| Akatchereian, C | 1 |
| Carde, P | 1 |
| Leclerq, B | 1 |
| Friedman, S | 1 |
| Droz, JP | 1 |
| Hayat, M | 1 |
10 other studies available for mercaptoethanol and Brain Disorders
| Article | Year |
|---|---|
Fatal encephalopathy with ifosfamide/mesna.
Topics: Brain Diseases; Child; Drug Therapy, Combination; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; | 1989 |
Encephalopathy associated with ifosphamide/mesna therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Cyclophosphamide; Female; Humans; If | 1985 |
Ifosfamide/mesa and encephalopathy.
Topics: Brain Diseases; Carcinoma, Small Cell; Cyclophosphamide; Female; Humans; Ifosfamide; Lung Neoplasms; | 1985 |
Ifosfamide, mesna, and encephalopathy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child; Cyclophosphamide; Fema | 1985 |
Avoiding ifosfamide/mesna encephalopathy.
Topics: Adolescent; Adult; Aged; Brain Diseases; Drug Therapy, Combination; Female; Humans; Ifosfamide; Male | 1986 |
Encephalopathy with rapid infusion ifosfamide/mesna.
Topics: Brain Diseases; Drug Therapy, Combination; Humans; Ifosfamide; Infusions, Intravenous; Mercaptoethan | 1987 |
[Encephalopathy caused by an ifosfamide-mesna combination].
Topics: Adult; Brain Diseases; Drug Therapy, Combination; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna | 1988 |
Prediction of ifosfamide/mesna associated encephalopathy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Electroencephalography; Female; Huma | 1986 |
Irreversible encephalopathy with ifosfamide/mesna.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child, Preschool; Dactinomycin; Fema | 1987 |
Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity.
Topics: Adolescent; Brain Diseases; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; | 1988 |